Introduction
============

Leiomyomas are benign smooth muscle neoplasms that arise from the myometrium and account for almost 75% of hysterectomy cases \[[@B1]\]. Such cases are mostly seen in women of reproductive age with a low incidence in postmenopausal age. Leiomyomas have numerous morphologies, among which cotyledonoid dissecting leiomyoma (CDL) is a very unusual form. Its rarity and unfamiliarity may lead to its misdiagnosis as a malignant tumor \[[@B2]\]. Here we describe a case of CDL in a post-menopausal woman who presented with lower abdominal pain and third-degree uterine prolapse and present a review of the literature.

Case report
===========

A 60-year-old woman presented with the complaint of a 1-year history of lower abdominal pain and third-degree uterovaginal descent. Her previous menstrual history was unremarkable. A vaginal examination revealed a bulky uterus with an ulceration on the anterior cervical lip. Ultrasonography revealed that the uterus was 7.5×3.4 cm in size with an endometrial thickness of 4.9 mm. Multiple uterine fibroids 2--4 cm in diameter were also noted. Both adenexa were unremarkable. A hysterectomy was performed and the specimen was sent for histopathological examination. Grossly, the cervix appeared hypertrophied and epidermidized. The endomyometrial thickness was 1.6 cm, while the endometrial thickness was 0.4 cm. Multiple fibroids up to 4×3.5 cm were noted. In addition, 2 subserosal fibroids 2 cm and 3.5 cm in diameter were seen. A cut section of the largest intramural fibroid and 1 subserosal fibroid revealed a solid, grayish-white, homogenous, and whorled appearance. The cut section of another subserosal fibroid revealed the presence of multiple grayish-white nodules ([Fig. 1A](#F1){ref-type="fig"}). Microscopy revealed nodules of varying sizes of uniform smooth muscles arranged in interlacing and whorling fascicles with few prominent blood vessels ([Fig. 1B--D](#F1){ref-type="fig"}). However, no signs of significant mitotic activity, nuclear atypia, or necrosis were seen. Based on the gross features and microscopic findings, a final diagnosis of CDL was made. Immunohistochemistry performed on CDL sections revealed diffuse positivity for vimentin, desmin, and smooth muscle actin, confirming the histopathological diagnosis of CDL ([Fig. 2](#F2){ref-type="fig"}). In the present case, this rare variant of leiomyoma was associated with multiple intramural and subserosal classical leiomyomas showing features of hyaline degeneration ([Fig. 3A](#F3){ref-type="fig"}). The endometrium was in the proliferative phase and adenomyosis was noted in the myometrium ([Fig. 3B](#F3){ref-type="fig"}). The cervix showed features of acute and chronic cervicitis with surface ulceration and keratinization.

![Gross and histopathology images of cotyledonoid dissecting leiomyoma. (A) Cut section with multiple tan white nodules. (B) Classical whorling pattern (hematoxylin and eosin \[HE\], ×20). (C) Nodules of varying sizes of uniform smooth muscles arranged in interlacing and whorling fascicles with few prominent blood vessels (HE, ×100). (D) Bland smooth muscles arranged in an interlacing pattern with no signs of nuclear atypia, mitosis, or necrosis (HE, ×400).](ogs-62-362-g001){#F1}

![Immunohistochemistry images of cotyledonoid dissecting leiomyoma showing: (A) smooth muscle actin (immunohistochemistry \[IHC\], ×400); (B) Vimentin (IHC, ×400); and (C) Desmin positivity in smooth muscle fibers (IHC, ×400).](ogs-62-362-g002){#F2}

![Histopathological images of intramural leiomyoma showing: (A) Benign smooth muscles arranged in an interlacing pattern with large areas of hyalinization (hematoxylin and eosin \[HE\], ×100) and myometrium; and (B) Features of adenomyosis (HE, ×40).](ogs-62-362-g003){#F3}

Discussion
==========

Leiomyomas are the most common benign smooth muscle neoplasms of the uterus. A number of patterns of leiomyomas have been described. CDL, a very rare variant that is also commonly known as Sternberg tumor, was first reported by Roth et al. \[[@B3]\] Menolascino-Bratta et al. \[[@B4]\] coined the term "angionodular dissecting leiomyoma". These tumors are frequently seen in the third to sixth decades of life. The most common complaints are lower abdominal pain and abnormal uterine bleeding. The apex case also presented with complaints of lower abdominal pain; however, no vaginal bleeding was revealed. Tumor size was typically 2--15 cm \[[@B4][@B5]\]. Three types of CDL have been described in the literature. The first appears as an exophytic mass of multinodular tissue protruding from the lateral surface of the uterine cornua; resembling the placenta is called CDL. The second type is an intramural dissecting tumor that is confined to the uterus. These 2 types share similar histopathological features. The last type is pure cotyledonoid leiomyoma, which is not associated with either a parent intramural mass or intramural dissection \[[@B6]\]. This case met the criteria for exophytic CDL. Microscopically, it is characterized by nodules of various sizes of uniform smooth muscles arranged in interlacing and whorling fascicles. Many blood vessels are also prominent with focal hypercellular areas. However, in contrast to malignant lesions, signs of mitotic activity, nuclear atypia, cellular pleomorphism, and necrosis are absent. Vascular invasion, capsular infiltration, and metastasis are not seen. In a few cases, perinodular hydropic changes may be prominent \[[@B7]\].

A variety of other unusual patterns of uterine leiomyoma have been described, such as parasitic leiomyoma, cellular leiomyoma, symplastic or bizarre leiomyoma, epithelioid leiomyoma, intravenous leiomyomatosis, and leiomyoma with secondary changes. Some CDL appear as large fungating masses with widespread extension into the broad ligament and pelvic cavity. Due to its rarity and a clinician's lack of familiarity, such tumors are sometimes misdiagnosed as malignancies \[[@B8]\].

Gurbuz et al. \[[@B9]\] reported a case of cotyledonoid leiomyoma that had no intrauterine portion but had extrauterine extensions. A comparative analysis of various CDL cases reported in the literature is given in [Table 1](#T1){ref-type="table"} and Supplementary Data 1.

###### Summary of the published cases of cotyledonoid dissecting leiomyoma

![](ogs-62-362-i001)

  SN        Reference                   Age   Clinical presentation       Tumor size (cm) maximum dimension   Tumor location
  --------- --------------------------- ----- --------------------------- ----------------------------------- -------------------------------------------------
  1         David et al. \[1\]          65    Abnormal uterine bleed      15                                  Uterine fundus and cervix
  48        Uterine prolapse            12    Uterine fundus                                                  
  2         Roth et al. \[2\]           39    Pelvic mass                 10.3                                Uterine cornua
  41        Abnormal uterine bleed      10    Uterine cornua                                                  
  23        Pelvic mass                 25    Uterine cornua                                                  
  Unknown   Pelvic mass                 24    Uterine cornua                                                  
  3         Brand et al. \[3\]          24    Abdominal mass              NA                                  Uterine fundus
  4         Roth and Reed \[4\]         46    Pelvic mass                 34                                  Uterine cornua
  5         Kim et al. \[5\]            26    Incidental                  12                                  Posterior uterine wall
  6         Cheuk et al. \[6\]          55    Abnormal uterine bleed      10                                  Uterine cornua
  7         Stewart et al. \[7\]        58    Abdominopelvic mass         16.4                                Uterine fundus
  8         Jordan et al. \[8\]         46    Right adnexal mass          22                                  Uterine with extrauterine extension (all cases)
  46        Pelvic mass                 20                                                                    
  46        Pelvic mass                 10                                                                    
  46        Pelvic mass                 18                                                                    
  36        Abnormal uterine bleed      13                                                                    
  34        Uterine mass, infertility   18                                                                    
  9         Saeed et al. \[9\]          27    Pelvic mass                 41                                  Uterine fundus
  10        Maimoon et al. \[10\]       40    Urinary retention           10                                  Uterine isthmus
  11        Shelekhova et al. \[11\]    73    Uterine mass                8                                   Uterine fundus
  12        Gurbuz et al. \[12\]        67    Incidental                  10                                  Uterine cornua
  13        Weissferdt et al. \[13\]    52    Abnormal uterine bleed      6.2                                 Uterine fundus
  14        Raga et al. \[14\]          33    Abdominal pain              6                                   Lateral part of uterus
  15        Driss et al. \[15\]         47    Pelvic mass                 25                                  Uterine with extrauterine extension
  16        Preda et al. \[16\]         41    Uterine mass                9                                   Left and posterior uterine wall
  17        Fukunaga et al. \[17\]      56    Constipation                30                                  Posterior uterine wall
  47        Abdominal pain              26    Posterior uterine wall                                          
  36        Abnormal uterine bleed      4     Posterior uterine wall                                          
  35        Abdominal pain              18    Lateral uterine wall                                            
  18        Gezginç et al. \[18\]       57    Pelvic pain                 2.5, 4.5                            Intrauterine, lateral uterine wall
  19        Agarwal et al. \[19\]       52    Abnormal uterine bleeding   10                                  Uterine cornua
  20        Ersöz et al. \[20\]         51    Abnormal uterine bleeding   8.5                                 Subserosal
  21        Roth et al. \[21\]          33    Abnormal uterine bleeding   6.5, 13.5                           Posterior uterine wall
  22        Tanaka et al. \[22\]        36    Incidental                  10                                  Posterior & lateral uterine wall
  23        Onu et al. \[23\]           50    Incidental                  10                                  Uterine fundus
  24        Kim et al. \[24\]           43    Abdominal mass              13                                  Uterine with extrauterine extension
  25        Blake et al. \[25\]         56    Abnormal uterine bleeding   30                                  Uterine with extrauterine extension
  26        Shimizu et al. \[26\]       40    Abnormal uterine bleeding   10                                  Posterior uterine wall
  27        Rocha et al. \[27\]         38    Abnormal uterine bleeding   25                                  Uterine isthmus
  28        Xu et al. \[28\]            55    Pelvic mass                 6                                   Posterior uterine wall
  43        Pelvic mass                 3     Body of uterus                                                  
  37        Pelvic mass                 30    Periuterine                                                     
  48        Lower abdominal pain        6.7   Right wall of uterus                                            

In conclusion, CDL is a unique and rare variant of leiomyoma with a characteristic gross nodular appearance and microscopic features. Increasing awareness among clinicians and pathologists regarding this rare entity will prevent inappropriate diagnosis and treatment.
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